Home > Resources > Whitepapers > The Challenges, Solutions, and Strategies Driving Pharmaceutical Supply Chain Innovation

The Challenges, Solutions, and Strategies Driving Pharmaceutical Supply Chain Innovation

In recent years, pharmaceutical and biotechnology companies have come to understand that supply chains ultimately impact the delivery of healthcare, and supply chains can and should serve as value centers for their company and the end-user. While there has always been a focus on the supply chain in relation to on-time delivery, there has traditionally been less focus on strategic inventory management and supply chain optimization. However, the importance of intelligent supply chain management has become a focus as pharma companies have been challenged with shifting regulatory compliance, emerging markets, item-level serialization, product diversification, and learning to use data to control costs and drive value.

I'm For Real

Enter your details once to access all our information and resources

 

Spotlight

Mowlam Healthcare Services

Mowlam Healthcare, established in 2000, is one of the largest independent healthcare providers of quality nursing home care in Ireland. On any one day Mowlam Healthcare will assist and care for over 1,300 residents. We believe that a good and effective healthcare culture can only emerge out of professional and compassionate values – Mowlam values that benefit not only our residents and their families, but fundamentally guide the role we play in developing and creating quality home-from-home environments throughout Ireland.

OTHER WHITEPAPERS
news image

The Ultimate Guide to Pharmaceutical Quality Managemen

whitePaper | October 20, 2022

When the first Nokia and Motorola cell phones that were affordable and small enough to fit in your pocket hit the market, they not only changed how we viewed phone technology but how we communicated.

Read More
news image

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More
news image

Adapting to Pharma’s Next Normal

whitePaper | October 4, 2022

Let’s just say what we’re all thinking: 2020 was rough. It threw every element of our lives into disarray. We suddenly had to become experts at navigating a new way of working, schooling and socialising. It was disruptive and it was challenging, but it was also transformative

Read More
news image

Non-Clinical Testing Considerations: Drugs vs Devices

whitePaper | November 8, 2022

While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most important difference is that medical devices do not achieve their principal action by pharmacological means.

Read More
news image

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More
news image

The Ultimate Guide to Digitizing Pharma Manufacturing

whitePaper | September 15, 2022

The sheer size of the pharmaceutical industry makes it important for all stakeholders to stay up to date with pharmaceutical industry trends.

Read More

The Ultimate Guide to Pharmaceutical Quality Managemen

whitePaper | October 20, 2022

When the first Nokia and Motorola cell phones that were affordable and small enough to fit in your pocket hit the market, they not only changed how we viewed phone technology but how we communicated.

Read More

Market Access Trends in the US, Europe, and Emerging Markets

whitePaper | November 14, 2022

Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.

Read More

Adapting to Pharma’s Next Normal

whitePaper | October 4, 2022

Let’s just say what we’re all thinking: 2020 was rough. It threw every element of our lives into disarray. We suddenly had to become experts at navigating a new way of working, schooling and socialising. It was disruptive and it was challenging, but it was also transformative

Read More

Non-Clinical Testing Considerations: Drugs vs Devices

whitePaper | November 8, 2022

While drugs and devices differ in their development, clinical trial phases and regulatory guidelines, the most important difference is that medical devices do not achieve their principal action by pharmacological means.

Read More

Blockchain technology in the pharmaceutical industry

whitePaper | March 11, 2022

Blockchain technology is accelerating digital transformation across multiple industries, including the pharmaceutical industry.

Read More

The Ultimate Guide to Digitizing Pharma Manufacturing

whitePaper | September 15, 2022

The sheer size of the pharmaceutical industry makes it important for all stakeholders to stay up to date with pharmaceutical industry trends.

Read More
More Whitepapers

Spotlight

Mowlam Healthcare Services

Mowlam Healthcare, established in 2000, is one of the largest independent healthcare providers of quality nursing home care in Ireland. On any one day Mowlam Healthcare will assist and care for over 1,300 residents. We believe that a good and effective healthcare culture can only emerge out of professional and compassionate values – Mowlam values that benefit not only our residents and their families, but fundamentally guide the role we play in developing and creating quality home-from-home environments throughout Ireland.

Events

2024 AAPS NATIONAL BIOTECHNOLOGY CONFERENCE

Conference